Vitamin D does not improve glycemic control in prediabetes

July 3, 2014
Vitamin D does not improve glycemic control in prediabetes

(HealthDay)—Supplementation with vitamin D does not appear to improve glycemic indices or cardiovascular risk factors in individuals with prediabetes, according to research published online June 19 in Diabetes Care.

Stina Therese Sollid, of the University of Tromsø in Norway, and colleagues randomly assigned 511 individuals with (IFG) or impaired glucose tolerance (IGT) to vitamin D3 or placebo.

At one year, the researchers observed no differences between the vitamin D group and placebo group in measures of glucose metabolism, insulin secretion, or insulin sensitivity. No differences were observed between the groups for blood pressure or serum high-sensitivity C-reactive protein level. Although a small but significant decrease in total and low-density lipoprotein cholesterol levels was observed in the vitamin D group compared with the , high-density lipoprotein (HDL) cholesterol level decreased, and the change in total/HDL cholesterol ratio was not significant.

"This study shows that vitamin D supplementation does not improve glycemic indices, blood pressure, or lipid status in subjects with IFG and/or IGT," the authors write.

Explore further: Vitamin D supplementation does not appear to reduce blood pressure in patients with hypertension

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

ECO: Pistachio nut consumption cuts insulin resistance

June 1, 2014

(HealthDay)—Consumption of pistachio nuts is associated with decreased insulin resistance in individuals with prediabetes, according to a study presented at the annual European Congress on Obesity, held from May 28 to 31 ...

Recommended for you

Diets avoiding dry-cooked foods can protect against diabetes

August 24, 2016

Simple changes in how we cook could go a long way towards preventing diabetes, say researchers at the Icahn School of Medicine at Mount Sinai. A new randomized controlled trial, published online July 29 in the journal Diabetologia, ...

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Gene variant explains differences in diabetes drug response

August 9, 2016

The first results from a large international study of patients taking metformin, the world's most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.